EP3721228A4 - Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health - Google Patents

Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health Download PDF

Info

Publication number
EP3721228A4
EP3721228A4 EP18885650.4A EP18885650A EP3721228A4 EP 3721228 A4 EP3721228 A4 EP 3721228A4 EP 18885650 A EP18885650 A EP 18885650A EP 3721228 A4 EP3721228 A4 EP 3721228A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
assay
treatment
point
care device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18885650.4A
Other languages
German (de)
French (fr)
Other versions
EP3721228A1 (en
Inventor
Damir Janigro
Aaron Dudas
Edward J. Rapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flotbi Inc
Original Assignee
Flotbi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/833,160 external-priority patent/US11717195B2/en
Application filed by Flotbi Inc filed Critical Flotbi Inc
Publication of EP3721228A1 publication Critical patent/EP3721228A1/en
Publication of EP3721228A4 publication Critical patent/EP3721228A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
EP18885650.4A 2017-12-06 2018-11-29 Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health Pending EP3721228A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/833,160 US11717195B2 (en) 2015-10-12 2017-12-06 Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affecting brain health
PCT/US2018/062937 WO2019112863A1 (en) 2017-12-06 2018-11-29 Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health

Publications (2)

Publication Number Publication Date
EP3721228A1 EP3721228A1 (en) 2020-10-14
EP3721228A4 true EP3721228A4 (en) 2021-12-15

Family

ID=66750327

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18885650.4A Pending EP3721228A4 (en) 2017-12-06 2018-11-29 Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health

Country Status (2)

Country Link
EP (1) EP3721228A4 (en)
WO (1) WO2019112863A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014075939A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft Novel mirnas as diagnostic markers
US20140242612A1 (en) * 2011-07-14 2014-08-28 Shuqi Wang System and method for integration of mobile device imaging with microchip elisa
US20150268252A1 (en) * 2009-06-19 2015-09-24 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
US20160203280A1 (en) * 2007-04-26 2016-07-14 Soar Biodynamics, Ltd. Methods and systems of delivering a probability of a medical condition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009075894A1 (en) * 2007-12-13 2009-06-18 Beckman Coulter, Inc Device and methods for detecting a target cell
JP6071886B2 (en) * 2010-10-14 2017-02-01 ザ・ジョンズ・ホプキンス・ユニバーシティ Brain injury biomarkers
US9686395B2 (en) * 2012-09-11 2017-06-20 Cornell University Apparatus and method for point-of-collection measurement of a biomolecular reaction
FI20155280A (en) * 2015-04-15 2016-10-16 Medicortex Finland Oy Prognostic and diagnostic glycan-based biomarkers for brain injury
EP3519824A1 (en) * 2016-10-03 2019-08-07 Abbott Laboratories Improved methods of assessing uch-l1 status in patient samples

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160203280A1 (en) * 2007-04-26 2016-07-14 Soar Biodynamics, Ltd. Methods and systems of delivering a probability of a medical condition
US20150268252A1 (en) * 2009-06-19 2015-09-24 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
US20140242612A1 (en) * 2011-07-14 2014-08-28 Shuqi Wang System and method for integration of mobile device imaging with microchip elisa
WO2014075939A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft Novel mirnas as diagnostic markers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019112863A1 *

Also Published As

Publication number Publication date
EP3721228A1 (en) 2020-10-14
WO2019112863A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
SG11202003337VA (en) Deep learning-based diagnosis and referral of ophthalmic diseases and disorders
EP3454745A4 (en) Diagnosis tailoring of health and disease
EP3827442A4 (en) Deep learning-based diagnosis and referral of diseases and disorders using natural language processing
EP3694409A4 (en) System for characterization, diagnosis, and treatment of a health condition of a patient and microtubule conductivity, and methods of using same
IL263985A (en) Medical device for treatment of a sinus and/or an ear and methods of use thereof
HK1246712A1 (en) Nerve stimulation for treatment of diseases and disorders
EP3844777A4 (en) Medical device and method for diagnosis and treatment of disease
EP3697925A4 (en) Identification and use of biological parameters for diagnosis and treatment monitoring
EP2967484A4 (en) System and signatures for the multi-modal physiological stimulation and assessment of brain health
ZA202006386B (en) Central nerve magnetic stimulation device and healthcare or medical instrument having same
EP3253445A4 (en) Early diagnosis and treatment of alzheimer disease and mild cognitive impairment
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
SG11202004971YA (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
EP3471562A4 (en) Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders
EP3554353A4 (en) System for characterization, diagnosis, and treatment of a health condition of a patient and methods of using same
EP3648769A4 (en) Human microbiota derived n-acyl amides for the treatment of human disease
EP3644966A4 (en) Treatment and diagnosis of ocular surface disorders
EP3518668A4 (en) Genetic susceptibility diagnosis and treatment of mental disorders
IL269400A (en) Drugs and compositions for the treatment of ocular disorders
EP3458045A4 (en) Treatment of meniere's disease
EP3852774A4 (en) Methods for diagnosis and treatment of type 1 diabetes
EP3746796A4 (en) Diagnosis and treatment of autism spectrum disorders based on amine containing metabotypes
EP3721228A4 (en) Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health
EP3737381A4 (en) Medical device and pharmaceutical composition for treatment of an eye disease or condition
EP3273982A4 (en) Method of diagnosis or treatment of neurological disorders with p75ecd and/or p75

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200625

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20211116

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20211111BHEP

Ipc: G01N 33/543 20060101ALI20211111BHEP

Ipc: G16H 50/20 20180101ALI20211111BHEP

Ipc: G01N 33/53 20060101AFI20211111BHEP